Quality Level
product line
ReagentPlus®
assay
99%
form
solid
mp
>300 °C (lit.)
SMILES string
O=C1NNC(=O)c2ccccc12
InChI
1S/C8H6N2O2/c11-7-5-3-1-2-4-6(5)8(12)10-9-7/h1-4H,(H,9,11)(H,10,12)
InChI key
KGLPWQKSKUVKMJ-UHFFFAOYSA-N
Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under 邻苯二甲酰肼
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
I H Hall et al.
The Journal of pharmacy and pharmacology, 41(6), 394-397 (1989-06-01)
The disposition of [14C]2,3-dihydrophthalazine-1,4-dione, a potent hypolipidaemic agent, has been determined after both intravenous and oral administration. Both the routes of administration afforded multi-exponential disposition with an estimated t1/2 of approximately 75 h. After oral administration, the drug was observed
J Schiller et al.
Free radical research, 30(1), 45-57 (1999-04-08)
The reactivity of 5-amino-2,3-dihydro-phthalazine-1,4-dione (luminol) and phthalic hydrazide with hydroxyl radicals was studied. HO*-radicals were generated by the Fenton reaction as well as by water radiolysis. Both luminol and phthalic hydrazide react with hydroxyl radicals under intense chemiluminescence (CL) emission.
I H Hall et al.
Anti-cancer drugs, 3(1), 55-62 (1992-02-01)
2,3-Dihydrophthalazine-1,4-dione derivatives demonstrated potent cytotoxicity against the growth of murine leukemia cells and human single cell suspension, i.e. Tmolt3 leukemia and HeLa-S3, as well as colon adenocarcinoma and KB nasopharynx. However, only select compounds demonstrated activity against bronchogenic lung, osteosarcoma
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| P38803-25G | 04061832500218 |